Pure Red Cell Aplasia Latest Advances
Find the Latest Research About Pure Red Cell Aplasia
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2949 publications
Identification of Human Transferrin Receptor as an Entry Co-receptor for Parvovirus B19 Infection of Human Erythroid Progenitor Cells.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Somatic Mutations in Acquired Pure Red Cell Aplasia: Incidence and Implications.
Journal: American journal of hematology
Published: March 28, 2026
Decoding immune-driven erythroid failure in pure red cell aplasia.
Journal: British journal of haematology
Published: March 18, 2026
Pure red cell aplasia in a patient with cold agglutinin disease-associated lymphoproliferative disorder
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: March 04, 2026
Steroid Responsiveness and Clinical Outcomes in Diamond-Blackfan Anemia: Analysis From the Canadian Inherited Marrow Failure Registry.
Journal: European journal of haematology
Published: March 02, 2026
Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination.
Journal: Internal medicine (Tokyo, Japan)
Published: February 15, 2026
Erratum for the Research Article "Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia".
Journal: Science translational medicine
Published: February 04, 2026
Yu L, Lemay P, Ludlow A, et al. A new murine Rpl5 (uL18) mutation provides a unique model of variably penetrant Diamond-Blackfan anemia. Blood Adv. 2021;5(20):4167-4178.
Journal: Blood advances
Published: January 30, 2026
Successful Treatment of Pure Red Cell Aplasia in Systemic Lupus Erythematosus With a Combination of Rituximab and Mycophenolate Mofetil.
Journal: Cureus
Published: January 28, 2026
Hematological immune-related adverse events associated with checkpoint inhibitors.
Journal: Cancer treatment reviews
Published: January 21, 2026
Somatic Mutations and Mutation Burden Predict Treatment Response and Survival in Adult Acquired Pure Red Cell Aplasia.
Journal: American journal of hematology
Published: January 21, 2026
Post-Transplant Cyclophosphamide Allows Allogeneic Hematopoietic Stem-Cell Transplantation Across Donor Types for Nonmalignant Hematologic Diseases.
Journal: Journal of hematology
Published: January 13, 2026
Last Updated: 04/28/2026